Skip to main content
. 2017 Apr 12;8(29):47250–47268. doi: 10.18632/oncotarget.16872

Table 4. Inhibitory effect of breast cancer cell line MCF-7 treated with GBK and VP-16.

Groups Dosage (g/ml) N OD value Inhibitory rate (%)
control 0 3 0.6217±0.06014 -
1+1 3 0.3863±0.01137 37.34
1+10 3 0.2243±0.05315 63.14
GBK+VP-16 5+5 3 0.3303±0.06461 45.96
5+10 3 0.2180±0.03318 64.35
10+10 3 0.1963±0.02108 68.06